logo
Select company
Select metric
0.86%Capital Expenditures Margin
VS
Market
83
Sector
76
Industry
92
History
71
$ 59.44Close
$ 51.75 - $ 68.52 52-Week Range
Ticker Information

Ticker

UTMD

Company Name

UTAH MEDICAL PRODUCTS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

UTAH MEDICAL PRODUCTS INC - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

UTMD - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 333K0.86%$ 38.83M
3/31/2025$ 392K1%$ 39.27M
12/31/2024$ 203K0.5%$ 40.9M
9/30/2024$ 284K0.64%$ 44.08M
6/30/2024$ 381K0.82%$ 46.58M
3/31/2024$ 591K1.21%$ 49.04M
12/31/2023$ 639K1.27%$ 50.22M
9/30/2023$ 587K1.14%$ 51.47M
6/30/2023$ 722K1.39%$ 51.91M
3/31/2023$ 615K1.17%$ 52.48M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UTAH MEDICAL PRODUCTS INC's latest trailing twelve months (TTM) CapEx % stands at 2.6%.
  • Over the past 5 years, UTAH MEDICAL PRODUCTS INC's average CapEx % has been 1.24%.
  • The median CapEx % for UTAH MEDICAL PRODUCTS INC during this period was 1.16%
  • UTAH MEDICAL PRODUCTS INC reached its highest CapEx % over the past 5 years at 2.6%.
  • The lowest CapEx % recorded by UTAH MEDICAL PRODUCTS INC in the same timeframe 0.5%

UTAH MEDICAL PRODUCTS INC's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
KRMD : KORU MEDICAL SYSTEMS INC 4.08%STXS : STEREOTAXIS INC 0.11%TLSI : TRISALUS LIFE SCIENCES INC 2.33%EDIT : EDITAS MEDICINE INC 8.8%CCCC : C4 THERAPEUTICS INC 0.49%VYGR : VOYAGER THERAPEUTICS INC 7.04%TKNO : ALPHA TEKNOVA INC 3.37%MXCT : MAXCYTE INC 5.01%RVP : RETRACTABLE TECHNOLOGIES INC 3.96%PDEX : PRO DEX INC 1.87%

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for UTAH MEDICAL PRODUCTS INC is calculated as follows: CapEx [ $ 1.09M ] / Revenues [ $ 42M ]
(=) CapEx % [ 2.6% ]

UTMD - Capital Expenditures Margin, Last 5 years

0.5%

Minimum

Dec 31, 2024

2.6%

Maximum

Sep 30, 2020

1.24%

Average

1.16%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.04%
average3.46%
median2.43%
std3.27%